Purple United Sales Ltd.
•₹ 411.24.99%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.2%
- Company has a healthy return on capital (ROCE) of 23.0%
- Operating margins have improved to 20.1% from 14.2%
- Attractively priced for its growth - PEG of 0.2
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -2.36x)
- Equity base is being diluted - shares outstanding up 73.5%
- Total debt has risen sharply - up 59.9% year on year
- Free cash flow has been persistently negative
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | DMART | 3979.55 | 84.88 | 259564.55 | 0.00 | 860.44 | 11.34 | 18794.53 | 14.88 | 18.03 | 7.98 |
| 2. | TRENT | 2944.00 | 86.78 | 156983.37 | 0.14 | 518.07 | 21.98 | 5754.71 | 17.84 | 36.73 | 19.45 |
| 3. | VMM | 103.40 | 54.31 | 48440.92 | 0.00 | 258.77 | 25.57 | 3727.01 | 18.68 | 17.13 | 14.61 |
| 4. | METROBRAND | 924.05 | 61.97 | 25186.40 | 0.32 | 95.26 | -3.58 | 720.36 | 14.66 | 33.25 | 29.85 |
| 5. | ABLBL | 86.92 | 60.28 | 10608.77 | 0.58 | 29.02 | 20.62 | 2045.74 | 11.15 | 27.34 | 15.06 |
| 6. | PNGJL | 603.90 | 19.94 | 8889.56 | 0.00 | 105.33 | 51.91 | 2412.98 | 40.73 | 20.40 | 7.56 |
| 7. | V2RETAIL | 220.00 | 44.90 | 8022.03 | 0.00 | 41.85 | 69.70 | 997.20 | 57.73 | 38.43 | 13.99 |
| 8. | AVL | 605.70 | 0.00 | 7821.89 | 0.21 | 77.22 | 39.99 | 1192.68 | 26.85 | 20.82 | 10.44 |
| 9. | MEDPLUS | 649.85 | 37.09 | 7807.11 | 0.00 | 33.17 | -21.67 | 1879.60 | 21.84 | 22.22 | 7.09 |
| 10. | ETHOSLTD | 2904.30 | 74.81 | 7771.24 | 0.00 | 28.66 | 50.71 | 461.71 | 33.32 | 13.70 | 12.97 |
| 11. | EMIL | 191.15 | 35.67 | 7354.47 | 0.00 | 120.64 | 458.07 | 2418.95 | 39.07 | 14.49 | 9.88 |
| 12. | PURPLEUTED | 384.60 | 0.00 | 369.59 | 0.00 | — | — | — | — | 26.21 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 17 | 26 | 43 | 103 | |
| 14 | 22 | 34 | 82 | |
| Operating Profit | 2 | 4 | 10 | 21 |
| OPM % | 15 | 15 | 22 | 20 |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 3 | 5 |
| Depreciation | 0 | 0 | 2 | 2 |
| 1 | 2 | 5 | 14 | |
| Tax % | -51 | 29 | 16 | 26 |
| Net Profit | 2 | 1 | 4 | 10 |
| EPS | 3 | 2 | 6 | 11 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 2 | 6 | 11 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 2 | 6 | 11 |
Mar 2022
- 17
- 14
- Operating Profit
- 2
- OPM %
- 15
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- -51
- Net Profit
- 2
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2023
- 26
- 22
- Operating Profit
- 4
- OPM %
- 15
- Other Income
- 0
- Interest
- 2
- Depreciation
- 0
- 2
- Tax %
- 29
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2024
- 43
- 34
- Operating Profit
- 10
- OPM %
- 22
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 5
- Tax %
- 16
- Net Profit
- 4
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 103
- 82
- Operating Profit
- 21
- OPM %
- 20
- Other Income
- 0
- Interest
- 5
- Depreciation
- 2
- 14
- Tax %
- 26
- Net Profit
- 10
- EPS
- 11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 84%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 81%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 90%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 25%
- Last Year:
- 27%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 6 | 6 | 7 | 10 |
| 1 | 4 | 11 | 51 | |
| 3 | 4 | 17 | 30 | |
| Trade Payables | 5 | 9 | 3 | 7 |
| 8 | 9 | 12 | 32 | |
| Total Liabilities | 22 | 32 | 49 | 130 |
| ASSETS | - | - | - | - |
| 1 | 4 | 5 | 15 | |
| 7 | 7 | 10 | 17 | |
| 0 | 0 | 29 | 60 | |
| Cash & Bank | 0 | 0 | 1 | 1 |
| 14 | 20 | 5 | 36 | |
| Total Assets | 22 | 32 | 49 | 130 |
| Total Debt | 11 | 12 | 26 | 41 |
| Net Working Capital | 13 | 13 | 21 | 62 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 11.14 | 17.05 | 26.14 | 62.99 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 11 | 12 | 26 | 41 |
| Net Working Capital | 13 | 13 | 21 | 62 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 11.14 | 17.05 | 26.14 | 62.99 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2022
- Equity Capital
- 6
- 1
- 3
- Trade Payables
- 5
- 8
- Total Liabilities
- 22
- 1
- 7
- 0
- Cash & Bank
- 0
- 14
- Total Assets
- 22
- Total Debt
- 11
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 11.14
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 11.14
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 6
- 4
- 4
- Trade Payables
- 9
- 9
- Total Liabilities
- 32
- 4
- 7
- 0
- Cash & Bank
- 0
- 20
- Total Assets
- 32
- Total Debt
- 12
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 17.05
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 17.05
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 7
- 11
- 17
- Trade Payables
- 3
- 12
- Total Liabilities
- 49
- 5
- 10
- 29
- Cash & Bank
- 1
- 5
- Total Assets
- 49
- Total Debt
- 26
- Net Working Capital
- 21
- Contingent Liabilities
- 0
- Book Value per Share
- 26.14
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 21
- Contingent Liabilities
- 0
- Book Value per Share
- 26.14
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 10
- 51
- 30
- Trade Payables
- 7
- 32
- Total Liabilities
- 130
- 15
- 17
- 60
- Cash & Bank
- 1
- 36
- Total Assets
- 130
- Total Debt
- 41
- Net Working Capital
- 62
- Contingent Liabilities
- 0
- Book Value per Share
- 62.99
- Face Value
- 10.00
- Total Debt
- 41
- Net Working Capital
- 62
- Contingent Liabilities
- 0
- Book Value per Share
- 62.99
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 1 | 4 | -11 | -31 | |
| Cash from Investing | -0 | -4 | -2 | -12 |
| Cash from Financing | -1 | 0 | 14 | 43 |
| 0 | 0 | 0 | 0 | |
| Free Cash Flow | 1 | -0 | -13 | -43 |
| OCF / Net Profit | 0.60 | 2.38 | -2.55 | -2.96 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 0.60 | 2.38 | -2.55 | -2.96 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- 1
- Cash from Investing
- -0
- Cash from Financing
- -1
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.60
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.60
- Cumulative 5-Year FCF
- 0
Mar 2023
- 4
- Cash from Investing
- -4
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- 2.38
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.38
- Cumulative 5-Year FCF
- 0
Mar 2024
- -11
- Cash from Investing
- -2
- Cash from Financing
- 14
- 0
- Free Cash Flow
- -13
- OCF / Net Profit
- -2.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.55
- Cumulative 5-Year FCF
- 0
Mar 2025
- -31
- Cash from Investing
- -12
- Cash from Financing
- 43
- 0
- Free Cash Flow
- -43
- OCF / Net Profit
- -2.96
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.96
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | 3.20 | 2.45 | 6.38 | 10.90 |
| Book Value (₹) | 11.14 | 17.05 | 26.14 | 62.99 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 3.53 | 2.89 | 8.74 | 12.79 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 14.20% | 14.75% | 21.92% | 20.09% |
| Net Margin % | 10.47% | 5.71% | 9.77% | 10.16% |
| ROE % | 28.71% | 18.05% | 30.54% | 26.90% |
| ROCE % | 12.87% | 18.19% | 24.75% | 26.21% |
| 8.03% | 5.50% | 10.47% | 11.72% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 250 | 205 | 196 | 158 |
| Inventory Days | 154 | 101 | 72 | 48 |
| Payable Days | 326 | 230 | 130 | 35 |
| 78 | 76 | 137 | 171 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 1.79x | 1.15x | 1.48x | 0.68x |
| Interest Coverage (x) | 2.12x | 2.39x | 2.66x | 3.90x |
| 2.62x | 1.98x | 1.97x | 2.29x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 55.55% | 68.51% | 138.19% |
| Operating Profit Growth % | 0.00% | 60.54% | 149.82% | 115.35% |
| Net Profit Growth % | 0.00% | -15.77% | 183.46% | 147.63% |
| 0.00% | 0.00% | 159.86% | 70.92% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 12.85x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 2.22x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 3.29x | 8.43x |
Mar 2022
- EPS (₹)
- 3.20
- Book Value (₹)
- 11.14
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.53
- Operating Margin %
- 14.20%
- Net Margin %
- 10.47%
- ROE %
- 28.71%
- ROCE %
- 12.87%
- 8.03%
- Debtor Days
- 250
- Inventory Days
- 154
- Payable Days
- 326
- 78
- Debt to Equity (x)
- 1.79x
- Interest Coverage (x)
- 2.12x
- 2.62x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 2.45
- Book Value (₹)
- 17.05
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.89
- Operating Margin %
- 14.75%
- Net Margin %
- 5.71%
- ROE %
- 18.05%
- ROCE %
- 18.19%
- 5.50%
- Debtor Days
- 205
- Inventory Days
- 101
- Payable Days
- 230
- 76
- Debt to Equity (x)
- 1.15x
- Interest Coverage (x)
- 2.39x
- 1.98x
- Revenue Growth %
- 55.55%
- Operating Profit Growth %
- 60.54%
- Net Profit Growth %
- -15.77%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 6.38
- Book Value (₹)
- 26.14
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.74
- Operating Margin %
- 21.92%
- Net Margin %
- 9.77%
- ROE %
- 30.54%
- ROCE %
- 24.75%
- 10.47%
- Debtor Days
- 196
- Inventory Days
- 72
- Payable Days
- 130
- 137
- Debt to Equity (x)
- 1.48x
- Interest Coverage (x)
- 2.66x
- 1.97x
- Revenue Growth %
- 68.51%
- Operating Profit Growth %
- 149.82%
- Net Profit Growth %
- 183.46%
- 159.86%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.29x
Mar 2025
- EPS (₹)
- 10.90
- Book Value (₹)
- 62.99
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 12.79
- Operating Margin %
- 20.09%
- Net Margin %
- 10.16%
- ROE %
- 26.90%
- ROCE %
- 26.21%
- 11.72%
- Debtor Days
- 158
- Inventory Days
- 48
- Payable Days
- 35
- 171
- Debt to Equity (x)
- 0.68x
- Interest Coverage (x)
- 3.90x
- 2.29x
- Revenue Growth %
- 138.19%
- Operating Profit Growth %
- 115.35%
- Net Profit Growth %
- 147.63%
- 70.92%
- P/E (x)
- 12.85x
- P/B (x)
- 2.22x
- Dividend Yield %
- 0.00%
- 8.43x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Jan 2026
Dec 2025